Meristomics

Meristomics is an early-stage spatial biology company focused on developing next-generation spatial genomics technologies. Founded by researchers from the Broad Institute of MIT and Harvard, the company leverages advancements in spatial transcriptomics to map cellular functions and gene expression within their native tissue environments. The platform aims to provide high-resolution, scalable solutions for understanding complex biological systems in both research and clinical settings. By integrating spatial context with genomic data, Meristomics seeks to accelerate the discovery of new biomarkers and therapeutic targets. The company is positioned to bridge the gap between single-cell sequencing and traditional histology.